Using a 100 µL sample size, most of the tested analytes were recovered at 70 percent or greater. The analytical response for the extracted analytes with high matrix effects was sufficient to achieve adequate recoveries and LODs. This method, therefore, supports the use of ISOLUTE® SLE+ for the screening of urine samples for various illicit and prescribed drugs.
Codeine, hydrocodone, oxycodone, norcodeine, oxymorphone, 6-acetyl codeine, alprazolam, clonazepam, diazepam, flunitrazepam, nitrazepam, oxazepam, temazepam, dextromethorphan, buprenorphine, norbuprenorphine, fentanyl, EDDP, benzoylecgonine, tetrahydrocannabinol, normeperidine, naltrexone, hydromorphone, propoxyphene, pentazocine, amphetamine, norfentanyl, MDEA, butalbital, pentobarbital, phenobarbital, secobarbital, 11-nor-9 –carboxy- Δ9-tetrahydrocannabinol, and d3-11-hydroxy-tetrahydrocannabinol.
Download the application note below.
Effective Purification of Peptides using Normal Phase Flash
Webinar Recording - Advances in Sample Preparation Using In-Well Hydrolysis for Urine Samples
Video Demonstration - the Software in Turbovap® Evaporators
A Holistic Approach to the Peptide Workflow in Drug Discovery
Here are 43 Clinical Applications in One Compendium